Our business model We use our six capitals and our unique value drivers to provide high quality, affordable medicines and create value for our stakeholders in a responsible and sustainable way. We develop our strategic objectives to provide the foundation for our plan of action to achieve our short-, medium- and longterm goals
We rely on our unique value drivers within our six capitals to effectively implement our strategy and business activities
To deliver a differentiated portfolio of high quality and affordable medicines to improve the health and quality of life of patients.
Intellectual
To optimise the strategic advantage of our integrated value chain.
Manufactured
• Trusted Aspen brand • Targeted and efficient product
• Complex manufacturing expertise • Vertical integration advantages • Globally competitive, scalable and widely accredited manufacturing facilities
portfolio renewal
• Strong presence in emerging markets
Product pipeline development
• Strong leadership team • High performance and innovative culture
Manufacturing and supply chain operations
Patient/consumer needs
We create value through our globally integrated value chain through carefully considering the trade-offs between capitals, aiming to maximise positive outcomes and limit any negative impacts
Human
Procurement API manufacturing FDF manufacturing Distribution
Product development, acquisition and registration
Investment in a product portfolio of niche, specialty medicines that present opportunities for sustainable revenue growth achieved through: • Targeted acquisitions that present value enhancement opportunities • Internal development of products that leverage our intellectual and manufacturing advantage • Line extensions of existing intellectual property into new geographies
Efficiencies achieved through end-to-end global supply chain management performed by a highly experienced team Capitalise on our own significant manufacturing capability of both APIs and FDFs as well as our external supply network focusing on: • Reliable supply of high quality products • Optimisation of operational costs • Maximisation of vertical integration synergies
Capital is reinvested in our pipeline to provide the platform for future revenue growth, improved operational synergies and to create capacity for new value-adding opportunities while also providing returns to shareholders
Achieving outcomes that create long-term value for our stakeholders
Improved health and quality of life for the patients and consumers that use our medicines Available online.
Reliable manufacture and supply of safe, efficacious, quality products that patients trust Available online.
Employment opportunities and skills development provided to our employees Available online.
Our governance framework supports our value creation process, ensuring we make choices that are aligned with our vision, values and strategic objectives, while being transparent and accountable for our actions. 08
Aspen Pharmacare Holdings Limited Corporate Brochure 2020
